Yuquan Tao
- Molecular Biology
- Cancer Research top 10%
- Oncology
- Pathology and Forensic Medicine
- Pulmonary and Respiratory Medicine
- Topics
- Hippo pathway signaling and YAP/TAZ (4 papers)MicroRNA in disease regulation (3 papers)Extracellular vesicles in disease (2 papers)
- Partner nations
- China
In The Last Decade
Yuquan Tao
14 papers receiving 517 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 313
- Cancer Research 230
- Oncology 98
- Pathology and Forensic Medicine 79
- Pulmonary and Respiratory Medicine 65
Countries citing papers authored by Yuquan Tao
This map shows the geographic impact of Yuquan Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuquan Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuquan Tao more than expected).
Fields of papers citing papers by Yuquan Tao
This network shows the impact of papers produced by Yuquan Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuquan Tao. The network helps show where Yuquan Tao may publish in the future.
Co-authorship network of co-authors of Yuquan Tao
This figure shows the co-authorship network connecting the top 25 collaborators of Yuquan Tao. A scholar is included among the top collaborators of Yuquan Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuquan Tao. Yuquan Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 96 | |
| 5 | 36 | |
| 6 | 37 | |
| 7 | 137 | |
| 8 | 46 | |
| 9 | 25 | |
| 10 | 28 | |
| 11 | The efficacy and safety of nivolumab, pembrolizumab, and atezolizumab in treatment of advanced non-small cell lung cancer. | 39 |
| 12 | 39 | |
| 13 | The Hippo signaling pathway: an emerging anti-cancer drug target. | 13 |
| 14 | 16 |
About Yuquan Tao
Yuquan Tao is a scholar working on Cancer Research, Geriatrics and Gerontology and Cell Biology, having authored 14 papers that have together received 524 indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (4 papers), MicroRNA in disease regulation (3 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Cancer Research (230 citations), Hepatology (49 citations) and Molecular Biology (313 citations). Yuquan Tao has collaborated with scholars based in China. Frequent co-authors include Xin Xu, Lifang Ma, Yongchun Yu, Feng Cai, Zijun Qian, Rui Chen, Hongyuan Jiang, Yongchun Yu, Zongguo Yang and Shan Liang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Oncotarget and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.